Nakata Hikaru, Tsubotani Yoshie, Nii Takuya, Hagi Akifumi, Inoue Yasuhide, Imamura Tadashi
Naruto Research Institute, Research and Development Center, Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan.
Ina Research Inc., Nagano, Japan.
J Med Microbiol. 2017 May;66(5):678-685. doi: 10.1099/jmm.0.000462. Epub 2017 May 18.
To determine the bactericidal efficacy of a new topical antiseptic for preoperative skin preparation, olanexidine gluconate (development code: OPB-2045G), against transient or resident bacterial flora on the skin of cynomolgus monkeys.
After measuring baseline bacterial counts on test sites marked on the abdomens, we applied olanexidine, chlorhexidine or povidone-iodine. After 10 min (fast-acting effect) and 6 h (long-lasting effect), bacterial counts were measured again and log10 reductions were calculated. In addition, we determined the bactericidal effects on the skin contaminated with blood before or after applying the antiseptics.
In the non-blood-contaminated condition, the mean log10 reductions of olanexidine at doses of 1-2 % were significantly higher than those of saline (negative control), but did not significantly differ from those of 0.5 % chlorhexidine and 10 % povidone-iodine at either time point. But olanexidine was significantly more effective at both time points than chlorhexidine and povidone-iodine when applied after the site was contaminated with blood. Olanexidine was also significantly more effective than chlorhexidine and as effective as or more effective than povidone-iodine at both time points when skin was contaminated with blood after the antiseptics were applied.
The bactericidal effects of olanexidine were comparable to those of commercial antiseptics such as chlorhexidine and povidone-iodine in non-blood-contaminated conditions. More importantly, the effect of olanexidine was hardly affected by blood unlike commercial antiseptics. Thus, it is considered that olanexidine has a favourable property for skin preparation in various types of surgical treatments.
确定一种用于术前皮肤准备的新型局部抗菌剂葡萄糖酸奥来尼定(研发代码:OPB - 2045G)对食蟹猴皮肤上的暂住菌或常驻菌丛的杀菌效果。
在测量腹部标记的测试部位的基线细菌计数后,我们应用了葡萄糖酸奥来尼定、氯己定或聚维酮碘。在10分钟(速效作用)和6小时(长效作用)后,再次测量细菌计数并计算log10减少量。此外,我们确定了在应用抗菌剂之前或之后对被血液污染的皮肤的杀菌效果。
在非血液污染条件下,1 - 2%剂量的葡萄糖酸奥来尼定的平均log10减少量显著高于生理盐水(阴性对照),但在两个时间点与0.5%氯己定和10%聚维酮碘的平均log10减少量均无显著差异。但是当测试部位被血液污染后应用时,葡萄糖酸奥来尼定在两个时间点均比氯己定和聚维酮碘显著更有效。当在应用抗菌剂后皮肤被血液污染时,葡萄糖酸奥来尼定在两个时间点也比氯己定显著更有效,并且与聚维酮碘效果相当或更有效。
在非血液污染条件下,葡萄糖酸奥来尼定的杀菌效果与氯己定和聚维酮碘等商用抗菌剂相当。更重要的是,与商用抗菌剂不同,葡萄糖酸奥来尼定的效果几乎不受血液影响。因此,认为葡萄糖酸奥来尼定在各种类型的外科治疗中具有用于皮肤准备的良好特性。